Drug Trial Radar · NCT06195072
Platform Clinical Study for Conquering Scleroderma
Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Apr 15, 2024
Primary completion
Nov 2026
Study completion Nov 2026
Sponsor
- Lead sponsor
- Scleroderma Research Foundation, Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sanofi; Boehringer Ingelheim
- First posted
- Jan 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.
Conditions
- Interstitial Lung Disease Due to Systemic Disease
- Scleroderma
Interventions
AmlitelimabDrug
IP will be administered subcutaneously by the Investigator or designee as follows: * Amlitelimab or * Matching placebo
BI 1015550 (Nerandomilast)Drug
Study participants will take the active investigational product BI 1015550 (Nerandomilast) or matching placebo provided as film-coated tablets, administered orally BID.
PlaceboDrug
see Experimental Arm intervention description
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change in forced vital capacity (FVC, in mL).Time frame: from baseline to the end of the treatment period at Week 52
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Division of Pulmonary and Critical Care Medicine
Birmingham, Alabama · Recruiting
Keck School of Medicine at USC Medical Center
Los Angeles, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
University of California, Los Angeles (UCLA) Ronald Reagan Medical Center
Los Angeles, California · Withdrawn
Stanford University Medical Center
Palo Alto, California · Recruiting
Yale University School of Medicine - Epilepsy
New Haven, Connecticut · Withdrawn
Georgetown University Medical Center - Department of Rheumatology
Washington D.C., District of Columbia · Recruiting
Emory University School of Medicine
Atlanta, Georgia · Withdrawn
Northwestern University
Chicago, Illinois · Completed
The University of Chicago Medical Center (UCMC)
Chicago, Illinois · Recruiting
University of Kansas School of Medicine
Kansas City, Kansas · Recruiting
Johns Hopkins University School of Medicine
Baltimore, Maryland · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Boston University (BU)
Boston, Massachusetts · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Washington University School of Medicine
St Louis, Missouri · Withdrawn
Robert Wood Johnson Medical School
New Brunswick, New Jersey · Recruiting
Northwell Health
Great Neck, New York · Recruiting
Hospital for Special Surgery
New York, New York · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Cleveland Clinic
Cleveland, Ohio · Withdrawn
Oregon Health & Science University (OHSU)
Portland, Oregon · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania · Recruiting
Temple University Hospital
Philadelphia, Pennsylvania · Withdrawn
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Withdrawn
Medical University of South Carolina (MUSC)
Charleston, South Carolina · Recruiting
Meharry Medical College
Nashville, Tennessee · Withdrawn
Vanderbilt University Medical Center
Nashville, Tennessee · Not yet recruiting
University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics
Houston, Texas · Recruiting
The University of Utah Health Sciences Center
Salt Lake City, Utah · Withdrawn
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.